BALAXI PHARMACEUTICALS LIMITED

Healthcare

NSE: BALAXI
₹22.78
Sept. 30, 2026 · NSE · nse_bhavcopy

Quarterly Financials

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 16 -1 -1 ₹
March 31, 2026 20 — — ₹
Dec. 31, 2025 25 2 2 ₹
Sept. 30, 2025 19 4 3 ₹
June 30, 2025 17 0 0 ₹
March 31, 2025 10 -1 -1 ₹
Dec. 31, 2024 11 2 2 ₹
Sept. 30, 2024 21 2 2 ₹
June 30, 2024 19 2 1 ₹
March 31, 2024 16 -0 -1 ₹
Dec. 31, 2023 13 1 0 ₹
Sept. 30, 2023 17 2 1 ₹
June 30, 2023 25 4 3 ₹

Annual Financials

Year endedRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)
March 31, 2026 81 5 1
March 31, 2025 61 5 4
March 31, 2024 70 6 4
March 31, 2023 108 22 16

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23
Total income (before exceptional items) — — ————
Operating revenue -9.2% — 816170108
Other income — — ————
Operating expenses — — ————
Operating profit — — ————
Operating profit margin — — ————
Depreciation — — ————
Interest — — ————
Exceptional items, gain / (loss) — — ————
Profit before tax -38.2% — 55622
Tax — — ————
Net profit -55.6% — 14416
EPS — — ————

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23
Operating margin————
EBIT margin————
PBT margin6.5%8.7%8.0%20.8%
Net margin1.8%5.9%5.2%15.0%
Interest coverage————
Dividend payout————
Earnings retention————
Current ratio————
Quick ratio————
Debt to equity————
Return on equity————
Return on assets————
Return on capital employed————
Asset turnover————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 — — 1 35 —
March 31, 2025 -8 -25 17 0 -8
March 31, 2024 -2 0 28 0 -2
March 31, 2023 -7 -2 26 0 -7
March 31, 2022 9 -7 -2 2 7

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 — — — — — — — — — —
March 31, 2025 — — — — — — — — — —
March 31, 2024 — — — — — — — — — —
March 31, 2023 — — — — — — — — — —
March 31, 2022 — — — — — — — — — —

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.